Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

263.55
-14.4700-5.20%
Volume:675.60K
Turnover:179.09M
Market Cap:7.34B
PE:-20.49
High:273.96
Open:273.74
Low:260.07
Close:278.02
52wk High:392.70
52wk Low:50.56
Shares:27.85M
Float Shares:24.08M
Volume Ratio:1.52
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:5.47
PE(LYR):-19.56

Loading ...

Praxis Precision Medicines Inc : Truist Securities Raises Target Price to $715 From $700

THOMSON REUTERS
·
May 13

Praxis Precision Medicines Maps High-Stakes Launch Path

TIPRANKS
·
May 12

Praxis Precision price target raised to $166 from $130 at Wedbush

TIPRANKS
·
May 08

Wedbush Remains a Sell on Praxis Precision Medicines (PRAX)

TIPRANKS
·
May 08

Deutsche Bank Adjusts Praxis Precision Medicines Price Target to $420 From $444, Maintains Buy Rating

MT Newswires Live
·
May 08

Praxis Precision Medicines Inc : Wedbush Raises Target Price to $166 From $130

THOMSON REUTERS
·
May 08

Praxis Precision Medicines, Inc. : Deutsche Bank Cuts Target Price to $420 From $444

THOMSON REUTERS
·
May 08

H.C. Wainwright Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)

TIPRANKS
·
May 08

Praxis Precision Med Price Target Maintained With a $843.00/Share by BTIG

Dow Jones
·
May 08

Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target

TIPRANKS
·
May 08

Praxis Precision Medicines publishes corporate presentation on CNS pipeline, near-term regulatory catalysts

Reuters
·
May 07

Praxis Precision's Q1 net loss widens on higher expenses

Reuters
·
May 07

Praxis Precision Medicine Q1 EPS $(3.20) Beats $(3.50) Estimate

Benzinga Earnings
·
May 07

BRIEF-Praxis Precision Q1 EPS USD -3.2

Reuters
·
May 07

Praxis Precision Q1 Operating Income USD -105.86 Million

THOMSON REUTERS
·
May 07

Praxis Precision Q1 Net Income USD -92.561 Million

THOMSON REUTERS
·
May 07

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Praxis Precision Medicines grants 5,420 RSUs to 21 new employees under inducement plan

Reuters
·
May 06

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06

Praxis Precision Medicines Inc expected to post a loss of $3.57 a share - Earnings Preview

Reuters
·
May 05